nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCG2—Vandetanib—thyroid cancer	0.115	0.173	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—thyroid cancer	0.102	0.154	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—thyroid cancer	0.0886	0.133	CbGbCtD
Omeprazole—ABCG2—Sorafenib—thyroid cancer	0.0694	0.104	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—thyroid cancer	0.0421	0.0631	CbGbCtD
Omeprazole—CYP2C8—Sorafenib—thyroid cancer	0.037	0.0554	CbGbCtD
Omeprazole—CYP2C19—Sorafenib—thyroid cancer	0.031	0.0465	CbGbCtD
Omeprazole—CYP1A2—Sorafenib—thyroid cancer	0.0286	0.0429	CbGbCtD
Omeprazole—CYP2C9—Sorafenib—thyroid cancer	0.0258	0.0387	CbGbCtD
Omeprazole—ABCB1—Sorafenib—thyroid cancer	0.025	0.0375	CbGbCtD
Omeprazole—CYP3A4—Vandetanib—thyroid cancer	0.0249	0.0373	CbGbCtD
Omeprazole—CYP2D6—Sorafenib—thyroid cancer	0.0236	0.0353	CbGbCtD
Omeprazole—ATP4A—larynx—thyroid cancer	0.0167	0.46	CbGeAlD
Omeprazole—ABCB1—Doxorubicin—thyroid cancer	0.0152	0.0228	CbGbCtD
Omeprazole—CYP3A4—Sorafenib—thyroid cancer	0.015	0.0225	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—thyroid cancer	0.0143	0.0214	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—thyroid cancer	0.0091	0.0136	CbGbCtD
Omeprazole—ATP4A—neck—thyroid cancer	0.00443	0.122	CbGeAlD
Omeprazole—ATP4A—head—thyroid cancer	0.00187	0.0515	CbGeAlD
Omeprazole—CYP11A1—head—thyroid cancer	0.00123	0.0338	CbGeAlD
Omeprazole—ABCC3—thyroid gland—thyroid cancer	0.00107	0.0295	CbGeAlD
Omeprazole—ABCG2—saliva-secreting gland—thyroid cancer	0.00102	0.0282	CbGeAlD
Omeprazole—ABCC3—head—thyroid cancer	0.000952	0.0262	CbGeAlD
Omeprazole—CYP11A1—lymph node—thyroid cancer	0.000859	0.0236	CbGeAlD
Omeprazole—CYP1B1—thyroid gland—thyroid cancer	0.00084	0.0231	CbGeAlD
Omeprazole—CYP1A1—trachea—thyroid cancer	0.00075	0.0207	CbGeAlD
Omeprazole—CYP1B1—head—thyroid cancer	0.000745	0.0205	CbGeAlD
Omeprazole—ABCC3—lymph node—thyroid cancer	0.000667	0.0184	CbGeAlD
Omeprazole—ABCG2—thyroid gland—thyroid cancer	0.000625	0.0172	CbGeAlD
Omeprazole—CYP1A2—thyroid gland—thyroid cancer	0.000602	0.0166	CbGeAlD
Omeprazole—CYP1A1—thyroid gland—thyroid cancer	0.000594	0.0163	CbGeAlD
Omeprazole—CYP1A1—head—thyroid cancer	0.000527	0.0145	CbGeAlD
Omeprazole—CYP1B1—lymph node—thyroid cancer	0.000522	0.0144	CbGeAlD
Omeprazole—ABCB1—trachea—thyroid cancer	0.00039	0.0107	CbGeAlD
Omeprazole—ABCG2—lymph node—thyroid cancer	0.000388	0.0107	CbGeAlD
Omeprazole—CYP2D6—head—thyroid cancer	0.00038	0.0105	CbGeAlD
Omeprazole—CYP1A1—lymph node—thyroid cancer	0.000369	0.0102	CbGeAlD
Omeprazole—ABCB1—thyroid gland—thyroid cancer	0.000308	0.00849	CbGeAlD
Omeprazole—ABCB1—head—thyroid cancer	0.000274	0.00753	CbGeAlD
Omeprazole—Purpura—Doxorubicin—thyroid cancer	0.000268	0.00103	CcSEcCtD
Omeprazole—Asthenia—Sorafenib—thyroid cancer	0.000266	0.00103	CcSEcCtD
Omeprazole—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000264	0.00102	CcSEcCtD
Omeprazole—Pruritus—Sorafenib—thyroid cancer	0.000262	0.00101	CcSEcCtD
Omeprazole—Blood creatinine increased—Epirubicin—thyroid cancer	0.000261	0.00101	CcSEcCtD
Omeprazole—Hyponatraemia—Doxorubicin—thyroid cancer	0.000259	0.000998	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000258	0.000994	CcSEcCtD
Omeprazole—Osteoarthritis—Doxorubicin—thyroid cancer	0.000258	0.000994	CcSEcCtD
Omeprazole—Diplopia—Doxorubicin—thyroid cancer	0.000258	0.000994	CcSEcCtD
Omeprazole—Pain in extremity—Doxorubicin—thyroid cancer	0.000258	0.000994	CcSEcCtD
Omeprazole—Dry skin—Epirubicin—thyroid cancer	0.000256	0.000985	CcSEcCtD
Omeprazole—Abdominal pain upper—Epirubicin—thyroid cancer	0.000255	0.000981	CcSEcCtD
Omeprazole—Migraine—Doxorubicin—thyroid cancer	0.000254	0.000979	CcSEcCtD
Omeprazole—Hypokalaemia—Epirubicin—thyroid cancer	0.000254	0.000978	CcSEcCtD
Omeprazole—Diarrhoea—Sorafenib—thyroid cancer	0.000254	0.000978	CcSEcCtD
Omeprazole—Breast disorder—Epirubicin—thyroid cancer	0.000252	0.000971	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000251	0.000968	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000251	0.000968	CcSEcCtD
Omeprazole—Face oedema—Doxorubicin—thyroid cancer	0.000249	0.00096	CcSEcCtD
Omeprazole—Gastritis—Epirubicin—thyroid cancer	0.000247	0.000951	CcSEcCtD
Omeprazole—Muscular weakness—Epirubicin—thyroid cancer	0.000246	0.000948	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000246	0.000948	CcSEcCtD
Omeprazole—Dizziness—Sorafenib—thyroid cancer	0.000245	0.000945	CcSEcCtD
Omeprazole—Abdominal distension—Epirubicin—thyroid cancer	0.000243	0.000935	CcSEcCtD
Omeprazole—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000242	0.000931	CcSEcCtD
Omeprazole—Influenza—Epirubicin—thyroid cancer	0.000241	0.000929	CcSEcCtD
Omeprazole—Dysphagia—Epirubicin—thyroid cancer	0.000241	0.000929	CcSEcCtD
Omeprazole—Asthma—Epirubicin—thyroid cancer	0.000241	0.000929	CcSEcCtD
Omeprazole—Dry skin—Doxorubicin—thyroid cancer	0.000237	0.000911	CcSEcCtD
Omeprazole—Pancreatitis—Epirubicin—thyroid cancer	0.000236	0.00091	CcSEcCtD
Omeprazole—Vomiting—Sorafenib—thyroid cancer	0.000236	0.000909	CcSEcCtD
Omeprazole—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000236	0.000908	CcSEcCtD
Omeprazole—Hypokalaemia—Doxorubicin—thyroid cancer	0.000235	0.000905	CcSEcCtD
Omeprazole—Angina pectoris—Epirubicin—thyroid cancer	0.000235	0.000905	CcSEcCtD
Omeprazole—Rash—Sorafenib—thyroid cancer	0.000234	0.000901	CcSEcCtD
Omeprazole—Dermatitis—Sorafenib—thyroid cancer	0.000234	0.0009	CcSEcCtD
Omeprazole—Breast disorder—Doxorubicin—thyroid cancer	0.000233	0.000898	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000232	0.000895	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000232	0.000895	CcSEcCtD
Omeprazole—Headache—Sorafenib—thyroid cancer	0.000232	0.000895	CcSEcCtD
Omeprazole—Pancytopenia—Epirubicin—thyroid cancer	0.000229	0.000882	CcSEcCtD
Omeprazole—Gastritis—Doxorubicin—thyroid cancer	0.000228	0.00088	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000228	0.000877	CcSEcCtD
Omeprazole—Muscular weakness—Doxorubicin—thyroid cancer	0.000228	0.000877	CcSEcCtD
Omeprazole—Dysuria—Epirubicin—thyroid cancer	0.000225	0.000868	CcSEcCtD
Omeprazole—Neutropenia—Epirubicin—thyroid cancer	0.000225	0.000868	CcSEcCtD
Omeprazole—Abdominal distension—Doxorubicin—thyroid cancer	0.000225	0.000865	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000224	0.000863	CcSEcCtD
Omeprazole—Influenza—Doxorubicin—thyroid cancer	0.000223	0.000859	CcSEcCtD
Omeprazole—Asthma—Doxorubicin—thyroid cancer	0.000223	0.000859	CcSEcCtD
Omeprazole—Dysphagia—Doxorubicin—thyroid cancer	0.000223	0.000859	CcSEcCtD
Omeprazole—Pollakiuria—Epirubicin—thyroid cancer	0.000223	0.000858	CcSEcCtD
Omeprazole—Nausea—Sorafenib—thyroid cancer	0.00022	0.000849	CcSEcCtD
Omeprazole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00022	0.000848	CcSEcCtD
Omeprazole—Weight increased—Epirubicin—thyroid cancer	0.000219	0.000845	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—thyroid cancer	0.000219	0.000842	CcSEcCtD
Omeprazole—Weight decreased—Epirubicin—thyroid cancer	0.000218	0.00084	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—thyroid cancer	0.000217	0.000837	CcSEcCtD
Omeprazole—Infestation—Epirubicin—thyroid cancer	0.000215	0.000828	CcSEcCtD
Omeprazole—Infestation NOS—Epirubicin—thyroid cancer	0.000215	0.000828	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000213	0.000821	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—thyroid cancer	0.000212	0.000816	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—thyroid cancer	0.000211	0.000814	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—thyroid cancer	0.00021	0.000807	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—thyroid cancer	0.00021	0.000807	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—thyroid cancer	0.000209	0.000805	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—thyroid cancer	0.000209	0.000805	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—thyroid cancer	0.000209	0.000803	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—thyroid cancer	0.000209	0.000803	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000207	0.000799	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—thyroid cancer	0.000206	0.000794	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—thyroid cancer	0.000205	0.000789	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000204	0.000784	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000203	0.000783	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—thyroid cancer	0.000203	0.000782	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—thyroid cancer	0.000203	0.000781	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—thyroid cancer	0.000202	0.000777	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—thyroid cancer	0.000202	0.000777	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—thyroid cancer	0.000201	0.000773	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—thyroid cancer	0.000199	0.000766	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—thyroid cancer	0.000199	0.000766	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000197	0.00076	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—thyroid cancer	0.000196	0.000757	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—thyroid cancer	0.000196	0.000753	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—thyroid cancer	0.000194	0.000747	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—thyroid cancer	0.000194	0.000747	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—thyroid cancer	0.000193	0.000745	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—thyroid cancer	0.000193	0.000745	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—thyroid cancer	0.000193	0.000745	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—thyroid cancer	0.000193	0.000743	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000192	0.00074	CcSEcCtD
Omeprazole—ABCB1—lymph node—thyroid cancer	0.000192	0.00527	CbGeAlD
Omeprazole—Pharyngitis—Epirubicin—thyroid cancer	0.000192	0.000738	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—thyroid cancer	0.000191	0.000734	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—thyroid cancer	0.00019	0.000732	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—thyroid cancer	0.00019	0.00073	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—thyroid cancer	0.00019	0.00073	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—thyroid cancer	0.000189	0.000729	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000188	0.000725	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—thyroid cancer	0.000188	0.000723	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—thyroid cancer	0.000187	0.000719	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—thyroid cancer	0.000186	0.000716	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—thyroid cancer	0.000186	0.000715	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—thyroid cancer	0.000182	0.000703	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—thyroid cancer	0.000182	0.0007	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—thyroid cancer	0.00018	0.000695	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—thyroid cancer	0.00018	0.000693	CcSEcCtD
Omeprazole—Flushing—Epirubicin—thyroid cancer	0.000179	0.00069	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—thyroid cancer	0.000179	0.00069	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—thyroid cancer	0.000179	0.000688	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000178	0.000684	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—thyroid cancer	0.000177	0.000683	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000176	0.000679	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000176	0.000678	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000175	0.000676	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—thyroid cancer	0.000175	0.000674	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—thyroid cancer	0.000174	0.000671	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000174	0.00067	CcSEcCtD
Omeprazole—Chills—Epirubicin—thyroid cancer	0.000173	0.000667	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—thyroid cancer	0.000172	0.000663	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—thyroid cancer	0.000171	0.000657	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—thyroid cancer	0.000169	0.000651	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000169	0.00065	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—thyroid cancer	0.000168	0.000647	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—thyroid cancer	0.000167	0.000643	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—thyroid cancer	0.000166	0.000641	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—thyroid cancer	0.000166	0.000638	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—thyroid cancer	0.000166	0.000638	CcSEcCtD
Omeprazole—Tension—Epirubicin—thyroid cancer	0.000165	0.000635	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—thyroid cancer	0.000164	0.000634	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—thyroid cancer	0.000163	0.000628	CcSEcCtD
Omeprazole—Back pain—Epirubicin—thyroid cancer	0.000162	0.000626	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—thyroid cancer	0.000162	0.000622	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—thyroid cancer	0.000161	0.000621	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000161	0.00062	CcSEcCtD
Omeprazole—Chills—Doxorubicin—thyroid cancer	0.00016	0.000617	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—thyroid cancer	0.000158	0.00061	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—thyroid cancer	0.000158	0.000608	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—thyroid cancer	0.000156	0.000603	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000156	0.0006	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—thyroid cancer	0.000155	0.000599	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—thyroid cancer	0.000155	0.000598	CcSEcCtD
Omeprazole—Agitation—Epirubicin—thyroid cancer	0.000154	0.000595	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—thyroid cancer	0.000153	0.00059	CcSEcCtD
Omeprazole—Tension—Doxorubicin—thyroid cancer	0.000153	0.000588	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—thyroid cancer	0.000152	0.000586	CcSEcCtD
Omeprazole—Malaise—Epirubicin—thyroid cancer	0.000151	0.000584	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—thyroid cancer	0.000151	0.000581	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—thyroid cancer	0.000151	0.000581	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—thyroid cancer	0.00015	0.000579	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—thyroid cancer	0.00015	0.000579	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—thyroid cancer	0.000149	0.000576	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—thyroid cancer	0.000148	0.000572	CcSEcCtD
Omeprazole—Cough—Epirubicin—thyroid cancer	0.000147	0.000565	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—thyroid cancer	0.000146	0.000564	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—thyroid cancer	0.000145	0.000559	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000144	0.000556	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—thyroid cancer	0.000144	0.000553	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—thyroid cancer	0.000143	0.000551	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—thyroid cancer	0.000143	0.000551	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—thyroid cancer	0.000143	0.000551	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—thyroid cancer	0.000143	0.00055	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—thyroid cancer	0.000143	0.000549	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000142	0.000547	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—thyroid cancer	0.000141	0.000544	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—thyroid cancer	0.00014	0.00054	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—thyroid cancer	0.00014	0.000539	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—thyroid cancer	0.00014	0.000538	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—thyroid cancer	0.000139	0.000536	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—thyroid cancer	0.000138	0.000532	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—thyroid cancer	0.000137	0.000529	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000137	0.000528	CcSEcCtD
Omeprazole—Infection—Epirubicin—thyroid cancer	0.000136	0.000525	CcSEcCtD
Omeprazole—Cough—Doxorubicin—thyroid cancer	0.000136	0.000522	CcSEcCtD
Omeprazole—Shock—Epirubicin—thyroid cancer	0.000135	0.00052	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—thyroid cancer	0.000134	0.000518	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000134	0.000517	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—thyroid cancer	0.000134	0.000517	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—thyroid cancer	0.000134	0.000515	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—thyroid cancer	0.000133	0.000513	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000133	0.000511	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—thyroid cancer	0.000132	0.00051	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—thyroid cancer	0.000132	0.00051	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—thyroid cancer	0.000132	0.00051	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—thyroid cancer	0.000132	0.000508	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000131	0.000506	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—thyroid cancer	0.000131	0.000504	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—thyroid cancer	0.000131	0.000503	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—thyroid cancer	0.000129	0.000498	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—thyroid cancer	0.000128	0.000493	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000127	0.000489	CcSEcCtD
Omeprazole—Infection—Doxorubicin—thyroid cancer	0.000126	0.000485	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000125	0.000481	CcSEcCtD
Omeprazole—Shock—Doxorubicin—thyroid cancer	0.000125	0.000481	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000124	0.000479	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000124	0.000478	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—thyroid cancer	0.000124	0.000478	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—thyroid cancer	0.000124	0.000477	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—thyroid cancer	0.000123	0.000475	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—thyroid cancer	0.000123	0.000474	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000123	0.000472	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—thyroid cancer	0.000122	0.000471	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—thyroid cancer	0.000122	0.000469	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—thyroid cancer	0.000121	0.000466	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—thyroid cancer	0.000121	0.000465	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—thyroid cancer	0.000119	0.000459	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000118	0.000456	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—thyroid cancer	0.000118	0.000455	CcSEcCtD
Omeprazole—Constipation—Epirubicin—thyroid cancer	0.000117	0.000452	CcSEcCtD
Omeprazole—Pain—Epirubicin—thyroid cancer	0.000117	0.000452	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000116	0.000445	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—thyroid cancer	0.000115	0.000442	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—thyroid cancer	0.000114	0.000439	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—thyroid cancer	0.000113	0.000436	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—thyroid cancer	0.000113	0.000435	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—thyroid cancer	0.000113	0.000434	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000112	0.000432	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—thyroid cancer	0.000112	0.00043	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—thyroid cancer	0.00011	0.000425	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00011	0.000422	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—thyroid cancer	0.000109	0.000421	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—thyroid cancer	0.000109	0.00042	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—thyroid cancer	0.000108	0.000418	CcSEcCtD
Omeprazole—Pain—Doxorubicin—thyroid cancer	0.000108	0.000418	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—thyroid cancer	0.000108	0.000417	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—thyroid cancer	0.000108	0.000417	CcSEcCtD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000107	0.00289	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000107	0.00288	CbGpPWpGaD
Omeprazole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000105	0.000403	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000104	0.0004	CcSEcCtD
Omeprazole—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.000104	0.0028	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000103	0.00279	CbGpPWpGaD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000103	0.00277	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000102	0.00275	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000101	0.00274	CbGpPWpGaD
Omeprazole—Hypersensitivity—Epirubicin—thyroid cancer	0.000101	0.000389	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—thyroid cancer	0.000101	0.000388	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—thyroid cancer	0.0001	0.000386	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—thyroid cancer	0.0001	0.000386	CcSEcCtD
Omeprazole—CYP2C18—Metabolism—NDUFA13—thyroid cancer	9.96e-05	0.00269	CbGpPWpGaD
Omeprazole—Asthenia—Epirubicin—thyroid cancer	9.84e-05	0.000379	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—thyroid cancer	9.7e-05	0.000374	CcSEcCtD
Omeprazole—ABCC3—Metabolism—NDUFA13—thyroid cancer	9.69e-05	0.00262	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.66e-05	0.00261	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	9.66e-05	0.00261	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.55e-05	0.00258	CbGpPWpGaD
Omeprazole—Diarrhoea—Epirubicin—thyroid cancer	9.38e-05	0.000361	CcSEcCtD
Omeprazole—CYP2C18—Metabolism—CHST14—thyroid cancer	9.37e-05	0.00253	CbGpPWpGaD
Omeprazole—Hypersensitivity—Doxorubicin—thyroid cancer	9.35e-05	0.00036	CcSEcCtD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	9.24e-05	0.00249	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CHST14—thyroid cancer	9.11e-05	0.00246	CbGpPWpGaD
Omeprazole—Asthenia—Doxorubicin—thyroid cancer	9.1e-05	0.000351	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—thyroid cancer	9.07e-05	0.000349	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—CP—thyroid cancer	9.01e-05	0.00243	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—TPR—thyroid cancer	9.01e-05	0.00243	CbGpPWpGaD
Omeprazole—Pruritus—Doxorubicin—thyroid cancer	8.97e-05	0.000346	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.86e-05	0.00239	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.86e-05	0.00239	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—HPGD—thyroid cancer	8.73e-05	0.00236	CbGpPWpGaD
Omeprazole—Vomiting—Epirubicin—thyroid cancer	8.72e-05	0.000336	CcSEcCtD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.69e-05	0.00235	CbGpPWpGaD
Omeprazole—Diarrhoea—Doxorubicin—thyroid cancer	8.68e-05	0.000334	CcSEcCtD
Omeprazole—Rash—Epirubicin—thyroid cancer	8.64e-05	0.000333	CcSEcCtD
Omeprazole—CYP1B1—Metabolism—MINPP1—thyroid cancer	8.64e-05	0.00233	CbGpPWpGaD
Omeprazole—Dermatitis—Epirubicin—thyroid cancer	8.64e-05	0.000333	CcSEcCtD
Omeprazole—Headache—Epirubicin—thyroid cancer	8.59e-05	0.000331	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—thyroid cancer	8.39e-05	0.000323	CcSEcCtD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.27e-05	0.00223	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.23e-05	0.00222	CbGpPWpGaD
Omeprazole—Nausea—Epirubicin—thyroid cancer	8.14e-05	0.000314	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—thyroid cancer	8.07e-05	0.000311	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	8.04e-05	0.00217	CbGpPWpGaD
Omeprazole—Rash—Doxorubicin—thyroid cancer	8e-05	0.000308	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—thyroid cancer	7.99e-05	0.000308	CcSEcCtD
Omeprazole—Headache—Doxorubicin—thyroid cancer	7.95e-05	0.000306	CcSEcCtD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.91e-05	0.00213	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MINPP1—thyroid cancer	7.86e-05	0.00212	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.7e-05	0.00208	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—AKT1—thyroid cancer	7.59e-05	0.00205	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—HPGD—thyroid cancer	7.55e-05	0.00204	CbGpPWpGaD
Omeprazole—Nausea—Doxorubicin—thyroid cancer	7.53e-05	0.00029	CcSEcCtD
Omeprazole—ABCC3—Metabolism—HPGD—thyroid cancer	7.34e-05	0.00198	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NDUFA13—thyroid cancer	7.34e-05	0.00198	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—RXRA—thyroid cancer	7.24e-05	0.00195	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.21e-05	0.00195	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.08e-05	0.00191	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.06e-05	0.00191	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	6.98e-05	0.00188	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.92e-05	0.00187	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CHST14—thyroid cancer	6.91e-05	0.00186	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.74e-05	0.00182	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.71e-05	0.00181	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NDUFA13—thyroid cancer	6.68e-05	0.0018	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—RXRA—thyroid cancer	6.64e-05	0.00179	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	6.59e-05	0.00178	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	6.54e-05	0.00176	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	6.4e-05	0.00173	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.3e-05	0.0017	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CHST14—thyroid cancer	6.28e-05	0.0017	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	6.21e-05	0.00168	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	6.21e-05	0.00168	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.16e-05	0.00166	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.11e-05	0.00165	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.96e-05	0.00161	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.93e-05	0.0016	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.88e-05	0.00159	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.75e-05	0.00155	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.74e-05	0.00155	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.66e-05	0.00153	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—HPGD—thyroid cancer	5.57e-05	0.0015	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.45e-05	0.00147	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.4e-05	0.00146	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MINPP1—thyroid cancer	5.32e-05	0.00144	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	5.32e-05	0.00144	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	5.12e-05	0.00138	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—HPGD—thyroid cancer	5.06e-05	0.00137	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—TPR—thyroid cancer	5.01e-05	0.00135	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PRKAR1A—thyroid cancer	4.93e-05	0.00133	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.91e-05	0.00132	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.88e-05	0.00132	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.65e-05	0.00125	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—RXRA—thyroid cancer	4.62e-05	0.00125	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NDUFA13—thyroid cancer	4.52e-05	0.00122	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.52e-05	0.00122	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.47e-05	0.00121	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.41e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.41e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.35e-05	0.00118	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—TPR—thyroid cancer	4.34e-05	0.00117	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	4.27e-05	0.00115	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CHST14—thyroid cancer	4.25e-05	0.00115	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MINPP1—thyroid cancer	4.25e-05	0.00115	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—TPR—thyroid cancer	4.22e-05	0.00114	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PRKAR1A—thyroid cancer	4.15e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.15e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MINPP1—thyroid cancer	4e-05	0.00108	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.97e-05	0.00107	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.91e-05	0.00105	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CHST14—thyroid cancer	3.9e-05	0.00105	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.76e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SLC5A5—thyroid cancer	3.75e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.75e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.7e-05	0.000999	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.61e-05	0.000975	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.56e-05	0.000962	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.52e-05	0.000949	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CHST14—thyroid cancer	3.48e-05	0.000939	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HPGD—thyroid cancer	3.43e-05	0.000925	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.4e-05	0.000919	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CHST14—thyroid cancer	3.4e-05	0.000917	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.39e-05	0.000916	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.37e-05	0.000911	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.36e-05	0.000906	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.36e-05	0.000906	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.3e-05	0.000892	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SLC5A5—thyroid cancer	3.25e-05	0.000876	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CHST14—thyroid cancer	3.2e-05	0.000864	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TPR—thyroid cancer	3.2e-05	0.000863	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CHST14—thyroid cancer	3.17e-05	0.000857	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SLC5A5—thyroid cancer	3.16e-05	0.000853	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—RXRA—thyroid cancer	3.15e-05	0.000851	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	3.15e-05	0.000849	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HPGD—thyroid cancer	3.14e-05	0.000848	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.11e-05	0.000839	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.07e-05	0.000828	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.96e-05	0.000799	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TPR—thyroid cancer	2.91e-05	0.000785	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.88e-05	0.000779	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.86e-05	0.000772	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.85e-05	0.00077	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HPGD—thyroid cancer	2.81e-05	0.000757	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.78e-05	0.000751	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HPGD—thyroid cancer	2.74e-05	0.000739	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—RXRA—thyroid cancer	2.73e-05	0.000736	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CHST14—thyroid cancer	2.71e-05	0.000732	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—RXRA—thyroid cancer	2.65e-05	0.000716	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.64e-05	0.000713	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.62e-05	0.000707	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.58e-05	0.000697	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HPGD—thyroid cancer	2.58e-05	0.000697	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HPGD—thyroid cancer	2.56e-05	0.00069	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.55e-05	0.000688	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.51e-05	0.000679	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC5A5—thyroid cancer	2.39e-05	0.000646	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.39e-05	0.000644	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.3e-05	0.000622	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.28e-05	0.000614	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.24e-05	0.000605	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.23e-05	0.000601	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HPGD—thyroid cancer	2.19e-05	0.00059	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.18e-05	0.000588	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.11e-05	0.00057	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CHST14—thyroid cancer	2.09e-05	0.000565	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.07e-05	0.00056	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RXRA—thyroid cancer	2.01e-05	0.000543	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—thyroid cancer	1.99e-05	0.000537	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TPR—thyroid cancer	1.97e-05	0.000532	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.96e-05	0.000528	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.94e-05	0.000523	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RXRA—thyroid cancer	1.83e-05	0.000494	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TPR—thyroid cancer	1.81e-05	0.000487	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.78e-05	0.000479	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.77e-05	0.000479	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.77e-05	0.000478	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.76e-05	0.000474	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—thyroid cancer	1.72e-05	0.000465	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HPGD—thyroid cancer	1.69e-05	0.000455	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—thyroid cancer	1.68e-05	0.000452	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TPR—thyroid cancer	1.61e-05	0.000435	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.61e-05	0.000435	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000428	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TPR—thyroid cancer	1.57e-05	0.000425	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.57e-05	0.000424	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—thyroid cancer	1.57e-05	0.000423	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.55e-05	0.000418	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TPR—thyroid cancer	1.48e-05	0.0004	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.47e-05	0.000398	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TPR—thyroid cancer	1.47e-05	0.000397	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.46e-05	0.000394	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.00039	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.44e-05	0.000388	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.38e-05	0.000373	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000369	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.35e-05	0.000366	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.35e-05	0.000365	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.33e-05	0.000358	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—thyroid cancer	1.32e-05	0.000356	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.31e-05	0.000354	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—thyroid cancer	1.27e-05	0.000343	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.27e-05	0.000342	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TPR—thyroid cancer	1.26e-05	0.000339	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RXRA—thyroid cancer	1.24e-05	0.000334	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000333	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000326	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.2e-05	0.000325	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—thyroid cancer	1.18e-05	0.000319	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.18e-05	0.000318	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—thyroid cancer	1.16e-05	0.000312	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—thyroid cancer	1.15e-05	0.00031	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000306	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.13e-05	0.000305	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	0.000302	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000299	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000298	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.1e-05	0.000297	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.03e-05	0.000278	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000274	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—thyroid cancer	9.99e-06	0.00027	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RXRA—thyroid cancer	9.89e-06	0.000267	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.86e-06	0.000266	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TPR—thyroid cancer	9.69e-06	0.000262	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	9.53e-06	0.000257	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—thyroid cancer	9.4e-06	0.000254	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RXRA—thyroid cancer	9.32e-06	0.000252	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RXRA—thyroid cancer	9.24e-06	0.000249	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—thyroid cancer	9.09e-06	0.000245	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.99e-06	0.000243	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.81e-06	0.000238	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—thyroid cancer	8.71e-06	0.000235	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—thyroid cancer	7.92e-06	0.000214	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RXRA—thyroid cancer	7.9e-06	0.000213	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—thyroid cancer	7.87e-06	0.000212	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—thyroid cancer	7.82e-06	0.000211	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.68e-06	0.000207	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.25e-06	0.000196	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—thyroid cancer	7.17e-06	0.000194	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—thyroid cancer	6.81e-06	0.000184	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—thyroid cancer	6.62e-06	0.000179	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—thyroid cancer	6.4e-06	0.000173	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—thyroid cancer	6.24e-06	0.000169	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—thyroid cancer	6.15e-06	0.000166	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RXRA—thyroid cancer	6.09e-06	0.000165	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—thyroid cancer	5.88e-06	0.000159	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—thyroid cancer	5.83e-06	0.000157	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.64e-06	0.000152	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—thyroid cancer	5.36e-06	0.000145	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.03e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—thyroid cancer	5.02e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—thyroid cancer	4.99e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—thyroid cancer	4.92e-06	0.000133	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—thyroid cancer	4.91e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.63e-06	0.000125	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.59e-06	0.000124	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—thyroid cancer	4.57e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—thyroid cancer	4.39e-06	0.000118	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—thyroid cancer	4.28e-06	0.000116	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—thyroid cancer	4.04e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—thyroid cancer	4e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.92e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—thyroid cancer	3.85e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—thyroid cancer	3.42e-06	9.23e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—thyroid cancer	3.09e-06	8.35e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.03e-06	8.17e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—thyroid cancer	2.83e-06	7.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—thyroid cancer	2.64e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—thyroid cancer	2.53e-06	6.83e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—thyroid cancer	2.47e-06	6.67e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—thyroid cancer	2.33e-06	6.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—thyroid cancer	2.31e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—thyroid cancer	1.97e-06	5.32e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—thyroid cancer	1.52e-06	4.11e-05	CbGpPWpGaD
